Showing results (11-20 of 19) with videos related to
Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
Journal of Hepatology|July 20, 2002
Contribution of mrp2 in alterations of canalicular bile formation by the endothelin antagonist bosentanLaura Fouassier, Nils Kinnman, Guillaume Lefèvre, et al.Journal of Hepatology|August 21, 2003
Structure and liver cell expression pattern of the HFE gene in the ratPetra Holmström, Vijole Dzikaite, Rolf Hultcrantz, et al.BMC Pulmonary Medicine|August 15, 2019
Patient-reported outcomes in patients with cystic fibrosis with a G551D mutation on ivacaftor treatment: results from a cross-sectional studyScott C Bell, Jochen G Mainz, Gordon MacGregor, et al.Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|May 25, 2022
VOCAL: An observational study of ivacaftor for people with cystic fibrosis and selected non-G551D-CFTR gating mutationsNicholas J Simmonds, C Kors van der Ent, Carla Colombo, et al.The American Journal of Pathology|February 24, 2009
Ezrin-radixin-moesin-binding phosphoprotein (EBP50), an estrogen-inducible scaffold protein, contributes to biliary epithelial cell proliferationLaura Fouassier, Peter Rosenberg, Martine Mergey, et al.Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|November 29, 2020
Lumacaftor/ivacaftor in people with cystic fibrosis with an A455E-CFTR mutationGitte Berkers, Renske van der Meer, Harry Heijerman, et al.Annals of the American Thoracic Society|October 23, 2020
Ivacaftor in People with Cystic Fibrosis and a <i>3849+10kb C</i>→<i>T</i> or <i>D1152H</i> Residual Function MutationEitan Kerem, Malena Cohen-Cymberknoh, Reuven Tsabari, et al.Cureus|August 18, 2025
GAP-CP: Gender, Age, and Presentation in Chest PainStephanos Ghobrial, Dimitrios Nasiakos, Nils Kinnman, et al.The New England Journal of Medicine|December 3, 2025
Trial of Pegcetacoplan in C3 Glomerulopathy and Immune-Complex MPGNFadi Fakhouri, Andrew S Bomback, Gema Ariceta, et al.Pageof 2